Poster
# 69

Main Page

6th Internet World Congress for Biomedical Sciences

IndexIndex
One-page version
Dynamic pages

Monoclonal antibody reacting with human middle ear cholesteatomas

Stephan Lolov(1), Dinka Petrova(2), Stanimir Kyurkchiev(3), George Edrev(4)
(1)Institute of Biology and Immunology of Reproduction. Bulgarian Academy of Sciences - Sofia. Bulgaria
(2)(3)Institute of Biology and Immunology of Reproduction; Bulg. Acad. Sci. - Sofia. Bulgaria
(4)Dept. Otorhinolaryngology. Transport Medical Institute - Sofia. Bulgaria

Discussion Board Contact address: Stephan Lolov
Institute of Biology and Immunology of Reproduction Bulgarian Academy of Sciences
73 Tzarigradsko shousse Sofia
1113 Bulgaria
lolov@mont.nbu.acad.bg
[ABSTRACT] [PRESENTATION] [Discussion Board]
Main Page Previous: ELISA for the measurement of IgY concentrations of hen’s and quail’s serum and yolk Previous: Vestibular Evoked Potentials with Caloric Stimulation PRESENTATION
[Immunology]
Next: Central Neurochemical Alterations Induced by Acute and Repeated Systemic Interleukin-2 Administration
[Otorhinolaryngology]
Next: Age and regional peculiarities of the microbe landscape of the nasal mucosa.

ABSTRACT

Cholesteatoma is a destructive lesion of the human middle ear with unrevealed etiopathogenesis. Immunohistochemical assays with specific monoclonal antibodies have been used to register expression and distribution of several well-known antigens. In this study, the authors have looked for abnormal or unknown cholesteatoma’s constituents generating monoclonal antibodies.

BALB/c mice were immunized with subcutaneous implantation of the cholesteatomas’ sac and matrix. Hybridomas have been generated following procedures known in the art. The screening for clones with specific antibodies production was done using ELISA against salt-water tissue extract and IF with paraffin embedded tissue sections.

The monoclonal antibody named 1F8 showed positive reaction in ELISA and in IF when tested against both cholesteatoma and ear canal skin. At the same time when supernatants from different cell and tissue cultures have been used as an antigen in ELISA, IF8 reacted only with cholesteatomas’ supernatant. In Western blot it recognizes three small bands and a prominent one, with MW of approximately 70 kD. Using immunohistochemistry the antigen was localized in the subepithelial connective tissue fibers of the skin and the cholesteatoma. The antigen of IF8 was detected in all tested cholesteatomas. Studies are now in progress to characterize the antigen in more details.


Keywords: cholesteatoma - monoclonal antibody -

Discussion Board
Discussion Board

Any Comment to this presentation?

[ABSTRACT] [PRESENTATION] [Discussion Board]

Main Page Previous: ELISA for the measurement of IgY concentrations of hen’s and quail’s serum and yolk Previous: Vestibular Evoked Potentials with Caloric Stimulation PRESENTATION
[Immunology]
Next: Central Neurochemical Alterations Induced by Acute and Repeated Systemic Interleukin-2 Administration
[Otorhinolaryngology]
Next: Age and regional peculiarities of the microbe landscape of the nasal mucosa.
Stephan Lolov, Dinka Petrova, Stanimir Kyurkchiev, George Edrev
Copyright © 1999-2000. All rights reserved.

Contador de visitas a la página

Last update: 17/01/00